Julia Walsh, CEO

Julia offers clients of Brand Medicine a wealth of strategic planning experience - she draws on over 2 decades of supporting clients with Brand Plan development, communication plan determination and tactical planning. Just a couple of her assignments are summarised below - feel free to email her today to enquire how she can provide powerful and efficient strategic brand planning support for your product. 

Julia led the global agency team for the launch of the DME & RVO indications for Lucentis with Novartis; as a key strategic advisor she designed and moderated a 2 day workshop run in Basel attended by over 30 product managers and medical leads from around the world. Collaborating closely with senior Clients her objective was to generate the strategic roadmap for the brand with the expanded indications. Julia was also instrumental in the development & execution of the global creative platform for these indications, with the ‘Bringing Life Back Into Focus’ campaign winning a creative excellence award. 

 Julia oversaw this Global portfolio for Bayer with a range of responsibilities:

Contribute to growth strategy development for Kogenate (Bayer), identifying and prioritizing leverage points to optimize the potential to connect the brand with suitable patients.

Support development of the Brand Plan for Kogenate (won the Bayer President’s Award for Excellence)

Global pre-launch preparations for the Bayer ‘protein-free’ Factor VIII

Global campaign development for ‘Bayer Hemophilia Care’, a corporate communication platform for the expanding products and services within the Bayer hemophilia portfolio